The Philippine Chamber of the Pharmaceutical Industry Inc. (PCPI) continues to be at the vanguard of efforts to address the challenges facing the local pharmaceutical industry. It stands tall as the one and sole voice of the Filipino-owned pharmaceutical companies in the field of health care.

The PCPI, in fact, opened the gateway for Filipino drug manufacturers and producers to be at par with its international competitors in quality but affordable medicines. It has successfully unriveted what used to hedge the landscape of expensive drugs monopoly in the county, thereby, opening the floodgates to more affordable quality medicines.

In collaboration with the government, the PCPI ensured that more and more Filipinos benefit from the remarkably low price of medicines in the market. Some local companies have joined and complied with the Government Mediated Access Price (GMAP) for cheaper medicines as part of their commitment under the UN Millennium Development Goals.

As competition for the provision of medicine and related health products intensify in today’s global environment, the PCPI has assumed the lead role to ensure the competitiveness of local pharmaceutical companies worldwide.

The PCPI was established in March 2004 when the country’s four major pharmaceutical organizations decided to merge into one cohesive group that would serve as its sole voice in Philippine business. These four national groups were: Chamber of Filipino Drug Manufacturers and Distributors, Inc. (CFDMD), Association of Drug Industries of the Philippines (ADIP), Association of Philippine Pharmaceutical Manufacturers (APPMAN), and Filipino Drug Association (FIDA) who joined later on. This happened during the term of PGMA at Lloyd Laboratories in Bulacan.
The Presidents of the four national associations were Ms. Marilou Buensuceso; Mr. Conrad Layug, Mrs. Zenaida D. Balajadia and Mr Edward Isaac respectively.

The new board of trustees was then President Gloria Macapagal - Arroyo witnessed the signing of the unification agreement of the associations.

Founding Board of Trustees

President:
Mr. Michael A. dela Cruz

VP Generics:
Mr. William P. Fabroa

VP Manufacturing:
Ms. Marilou Buensuceso

VP Ethical Marketing:
Mr. Edward Isaac

Treasurer:
Theresita T. Chan

Secretary:
Atty. Ma. Leah J. Sebastian

P.R.O.:
Rodolfo B. Calma

Directors:
Zenaida D. Balajadia
James Dio
Sheila Mae M. Velilla

The merger came at the most auspicious of times, as the Philippines continued to struggle to bring affordable and quality health care to all Filipinos nationwide. Part of this struggle was to provide medicines with which to treat the more common diseases and whose prices were considered one of the highest in the world.

Key strategies

1. Empower members and customers

At the forefront of PCPI’s work is creating a setting for continuous learning. By continually improving the industry’s technical capability and marketing prowess, building cooperation and friendship within the organization and the bringing together of PCPI members to reduce cost of research and product development, members are equipped to meet the global challenges they face.
2. Build a supportive business environment

The second strategy sought to create a strong partnership with medical and allied healthcare professionals, government agencies and other relevant stakeholders. This aimed to pave the way to a supportive business environment that will allow market forces to make medicines more affordable to benefit the Filipinos by providing a credible alternative.
3. Deliver differentiated and cost-effective products

The PCPI encourages its members to stand out in the industry. Through its various programs, PCPI empowers its members to excel by bringing differentiated and cost-effective products to the market successfully.

Founding Board of Trustees

President:
Mr. Michael A. dela Cruz

VP Generics:
Mr. William P. Fabroa

VP Manufacturing:
Ms. Marilou Buensuceso

VP Ethical Marketing:
Mr. Edward Isaac

Treasurer:
Theresita T. Chan

Secretary:
Atty. Ma. Leah J. Sebastian

P.R.O.:
Rodolfo B. Calma

Directors:
Zenaida D. Balajadia
James Dio
Sheila Mae M. Velilla

Key strategies

1. Empower members and customers

At the forefront of PCPI’s work is creating a setting for continuous learning. By continually improving the industry’s technical capability and marketing prowess, building cooperation and friendship within the organization and the bringing together of PCPI members to reduce cost of research and product development, members are equipped to meet the global challenges they face.
2. Build a supportive business environment

The second strategy sought to create a strong partnership with medical and allied healthcare professionals, government agencies and other relevant stakeholders. This aimed to pave the way to a supportive business environment that will allow market forces to make medicines more affordable to benefit the Filipinos by providing a credible alternative.
3. Deliver differentiated and cost-effective products

The PCPI encourages its members to stand out in the industry. Through its various programs, PCPI empowers its members to excel by bringing differentiated and cost-effective products to the market successfully.

pcpi

Philippine Chamber of the
Pharmaceutical Industry, Inc.

Vision

A Globally
Competitive Filipino
Pharmaceutical Industry

Mission

Enable the
Filipino pharmaceutical
industry to LEAD

Values

Passion for excellence,
service oriented,
unity in diversity

Through PCPI's collective efforts,
it has designed strategies and
programs that seel to achieve its
mission and vision.

The result of which is a healthy
Filipino citizenry and a thriving
Filipino Pharmaceutical Industry.

More competition, more quality
products, better affordability,
better patience compliance.

136-B Scout Fuentebella, Brgy. Sacred Heart, Quezon City
Email Address: This email address is being protected from spambots. You need JavaScript enabled to view it.